Literature DB >> 2263166

Effect of L-carnitine and acetyl-L-carnitine on the human erythrocyte membrane stability and deformability.

A Arduini1, M Rossi, G Mancinelli, M Belfiglio, R Scurti, G Radatti, S B Shohet.   

Abstract

In this study we examined the effect of carnitine and acetylcarnitine on the human erythrocyte membrane stability and membrane deformability. Since erythrocyte membranes are impermeable to these compounds, we resealed erythrocyte ghosts in the presence of different concentrations of carnitine or acetylcarnitine. Resealed ghosts can be adequately studied in their cellular deformability and membrane stability properties by means of ektacytometry. Both carnitine and acetylcarnitine alter the membrane stability but not membrane deformability of the red cell membrane. Resealed ghosts containing 20, 50, 150, and 300 microM carnitine had 1.1, 1.6, 0.9, and 0.7 times the normal stability. While resealed ghosts containing 20, 50, 150, and 300 microM acetylcarnitine had 1.1, 1.5, 1.3, and 1.2 times the normal stability. Such changes were found to be reversible. We also conducted SDS PAGE of cytoskeletal membrane proteins from membrane fragments and residual membranes produced during membrane stability analysis, and unsheared resealed membranes in those samples where we observed an increase or a decrease of membrane stability. No changes in the cytoskeletal membrane proteins were noticed, even when the samples, prior SDS PAGE analysis, were treated with or without dithiothreitol. In addition, fluorescence steady state anisotropy of DPH in the erythrocyte membrane treated with carnitine or acetylcarnitine shows no modification of the lipid order parameter. Our results would suggest that both carnitine and its acetyl-ester, at physiological concentrations, may increase membrane stability in mature erythrocytes, most likely via a specific interaction with one or more cytoskeletal proteins, and that this effect would manifest when the erythrocytes are subjected to high shear stress.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2263166     DOI: 10.1016/0024-3205(90)90483-8

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  9 in total

Review 1.  The use of levo-carnitine in children with renal disease: a review and a call for future studies.

Authors:  Brook Belay; Nora Esteban-Cruciani; Christine A Walsh; Frederick J Kaskel
Journal:  Pediatr Nephrol       Date:  2005-12-23       Impact factor: 3.714

2.  Activity of lactate dehydrogenase in serum and cerebral cortex of immature and mature rats after hypobaric hypoxia.

Authors:  Jitka Koudelová; Hana Rauchová; Martina Vokurková
Journal:  Neurochem Res       Date:  2006-06-29       Impact factor: 3.996

3.  Acylcarnitines at the Membrane Surface: Insertion Parameters for a Mitochondrial Leaflet Model.

Authors:  Wajih Anwer; Amanda Ratto Velasquez; Valeria Tsoukanova
Journal:  Biophys J       Date:  2020-01-22       Impact factor: 4.033

4.  Propionyl-L-carnitine hydrochloride for treatment of mild to moderate colonic inflammatory bowel diseases.

Authors:  Giuseppe Merra; Giovanni Gasbarrini; Lucrezia Laterza; Marco Pizzoferrato; Andrea Poscia; Franco Scaldaferri; Vincenzo Arena; Francesca Fiore; Achille Cittadini; Alessandro Sgambato; Francesco Franceschi; Antonio Gasbarrini
Journal:  World J Gastroenterol       Date:  2012-09-28       Impact factor: 5.742

5.  l-carnitine as a Potential Additive in Blood Storage Solutions: A Study on Erythrocytes.

Authors:  R Soumya; H Carl; R Vani
Journal:  Indian J Hematol Blood Transfus       Date:  2015-07-11       Impact factor: 0.900

Review 6.  Pharmacokinetics of L-carnitine.

Authors:  Allan M Evans; Gianfranco Fornasini
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

7.  Long-term L-carnitine administration reduces erythropoietin resistance in chronic hemodialysis patients with thalassemia minor.

Authors:  Biagio R Di Iorio; Pasquale Guastaferro; Nicola Cillo; Emanuele Cucciniello; Vincenzo Bellizzi
Journal:  Drug Target Insights       Date:  2007-01-24

Review 8.  Significance of Levocarnitine Treatment in Dialysis Patients.

Authors:  Hiroyuki Takashima; Takashi Maruyama; Masanori Abe
Journal:  Nutrients       Date:  2021-04-07       Impact factor: 5.717

9.  Effects of acetyl-L-carnitine and methylcobalamin for diabetic peripheral neuropathy: A multicenter, randomized, double-blind, controlled trial.

Authors:  Sheyu Li; Xiang Chen; Qianrui Li; Juan Du; Zhimin Liu; Yongde Peng; Mian Xu; Qifu Li; Minxiang Lei; Changjiang Wang; Shaoxiong Zheng; Xiaojuan Zhang; Hongling Yu; Jinyu Shi; Shibing Tao; Ping Feng; Haoming Tian
Journal:  J Diabetes Investig       Date:  2016-03-28       Impact factor: 4.232

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.